Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Respiratory Medicine|February 3, 2022
Can FeNO be a biomarker in the post-COVID-19 patients monitoring?Mauro Maniscalco, Pasquale Ambrosino, Remo Poto, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|June 2, 2020
Effect of pulmonary rehabilitation on functional exercise capacity and hypoxemia in patients with interstitial lung diseases: a retrospective studySalvatore Fuschillo, Alberto De Felice, Andrea Elia, et al.
Respiratory Medicine|May 22, 2021
Preexisting cardiorespiratory comorbidity does not preclude the success of multidisciplinary rehabilitation in post-COVID-19 patientsMauro Maniscalco, Salvatore Fuschillo, Pasquale Ambrosino, et al.
Medicina (Kaunas, Lithuania)|April 23, 2022
Peripheral Neuropathy in Patients Recovering from Severe COVID-19: A Case SeriesPietro Balbi, Annamaria Saltalamacchia, Francesco Lullo, et al.
Cells|February 15, 2022
Metabolomics of COPD Pulmonary Rehabilitation Outcomes via Exhaled Breath CondensateMauro Maniscalco, Debora Paris, Paola Cuomo, et al.
Cells|November 10, 2023
Exhaled Nitric Oxide as Biomarker of Type 2 DiseasesMauro Maniscalco, Salvatore Fuschillo, Ilaria Mormile, et al.
ERJ Open Research|May 20, 2026
Skeletal muscle dysfunction in COPD: miRNAs, myokines and exerciseMauro Maniscalco, Salvatore Fuschillo, Pasquale Ambrosino, et al.
Annals of Medicine|September 16, 2021
Performance of fractional exhaled nitric oxide in predicting response to inhaled corticosteroids in chronic cough: a meta-analysisPasquale Ambrosino, Mariasofia Accardo, Marco Mosella, et al.
Journal of Personalized Medicine|November 24, 2022
Fractional Exhaled Nitric Oxide (FeNO) in Patients with Stable Chronic Obstructive Pulmonary Disease: Short-Term Variability and Potential Clinical ImplicationsPasquale Ambrosino, Salvatore Fuschillo, Mariasofia Accardo, et al.
Pageof 4